-
Nelarabine (Arranon) by GlaxoSmithKline. The FDA has approved nelarabine (Arranon) to treat adults and children with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), whose disease has not responded to or has relapsed following at least two chemotherapy regimens.
-
Mechanism of action, Pharmacokinetics, Dosage, Clinical studies, Strengths, Weaknesses, Drug interactions, Adverse reactions, Warnings/precautions, Monitoring, Cost comparison, Summary and recommendations
-
The FDA has begun requiring drug manufacturers to submit prescription drug label information to the agency in a new electronic format.
-
Results from recent published trials have shown much promise in the use of trastuzumab (Herceptin) plus adjuvant chemotherapy in patients with HER2-positive early-stage breast cancer.
-
Dont expect a repeat of last years shortage of influenza vaccine this winter. Do expect, however, to hear more about preparing for a possible avian flu pandemic.
-
Ziconotide (Prialt) is a synthetic equivalent of a naturally occurring conopeptide found in the piscivorous marine snail used intrathecally for severe chronic pain relief, and administered only in the Medtronic SynchroMed EL, SynchroMed II Infusion System, and Simms Deltec Cadd Micro External Microinfusion Device and Catheter.
-
Metformin hydrochloride (HCl) (Glumetza) by Biovail Corp. and Depomed. The FDA has approved metformin HCl (Glumetza), a once-daily, extended-release formulation for the treatment of Type II diabetes.
-
A review of adverse events reported to the FDA raises concern about the relative safety of rosuvastatin (Crestor) at its commonly used doses, researchers say. Some health professionals downplayed the study, however, saying the results still highlight the safety of statins for their indicated uses.
-
The Centers for Disease Control (CDC) in Atlanta has announced that the supply of inactivated influenza vaccine projected for the 2005-06 season should be adequate to meet the historical demand from persons in the priority groups established by Advisory Committee on Immunization Practices (ACIP) during the 2004-05 season.
-
Lenalidomide (Revlimid) can help some patients with myelodysplastic syndromes (MDS) avoid the need for blood transfusions, and even reduce or eliminate the genetic abnormality that characterizes the disease in this subset of patients, according to a new study.
